Moreover, CD34, CD45, CD99, HLA-DR, Terminal deoxynucleotidyl transferase (TdT), and CD38 are commonly used as progenitor markers for diagnosing and classifying AML (Weir and Borowitz, 2001, Peters and Ansari, 2011). The gene discussed is CD34; the disease is acute myeloid leukemia.